Paradoxical effect of Klebsiella pneumoniae OmpK36 porin deficiency

References

• Jacoby G A. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22: 161–182
   PubMed Web of Science ®Google Scholar
• Hernandez-Alles S, Alberti S, Alvarez D, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 1999; 145(3)673–679
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L, Pascual A, Hernandez-Alles S, et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999; 43: 1669–1673
   PubMed Web of Science ®Google Scholar
• Hernandez-Alles S, Conejo M, Pascual A, Tomas J M, Benedi V J, Martinez-Martinez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 2000; 46: 273–277
   PubMed Web of Science ®Google Scholar
• Livermore D M. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–584
   PubMed Web of Science ®Google Scholar
• Lartigue M F, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007; 51: 2855–2860
   PubMed Web of Science ®Google Scholar
• Perez-Perez F J, Hanson N D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153–2162
   PubMed Web of Science ®Google Scholar
• Valenzuela J K, Thomas L, Partridge S R, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer within a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 453–460
   PubMed Web of Science ®Google Scholar
• Carattoli A, Bertini A, Villa L, Falbo V, Hopkins K L, Threlfall E J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219–228
   PubMed Web of Science ®Google Scholar
• Menard R, Sansonetti P J, Parsot C. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol 1993; 175: 5899–5906
   PubMed Web of Science ®Google Scholar
• Ogunniyi A D, Kotlarski I, Morona R, Manning P A. Role of SefA subunit protein of SEF14 fimbriae in the pathogenesis of Salmonella enterica serovar Enteritidis. Infect Immunol 1997; 65: 708–717
   PubMed Web of Science ®Google Scholar
• Philippon A, Arlet G, Jacoby G A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002; 46: 1–11
   PubMed Web of Science ®Google Scholar
• Zong Z, Partridge S R, Thomas L, Iredell J R. Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool. Antimicrob Agents Chemother 2008; 52: 4198–4202
   PubMed Web of Science ®Google Scholar
• Bradford P A, Urban C, Mariano N, Projan S J, Rahal J J, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41: 563–569
   PubMed Web of Science ®Google Scholar
• Cao V T, Arlet G, Ericsson B M, Tammelin A, Courvalin P, Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 2000; 46: 895–900
   PubMed Web of Science ®Google Scholar
• Stapleton P D, Shannon K P, French G L. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43: 1206–1210
   PubMed Web of Science ®Google Scholar
• Pages J M, James C E, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 2008; 6: 893–903
   PubMed Web of Science ®Google Scholar
• Espedido B, Iredell J, Thomas L, Zelynski A. Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: implications of the variable phenotype. J Clin Microbiol 2005; 43: 4918–4919
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14(Suppl 1)82–89
   PubMed Web of Science ®Google Scholar
• Domenech-Sanchez A, Martinez-Martinez L, Hernandez-Alles S, et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 2003; 47: 3332–3335
   PubMed Web of Science ®Google Scholar
• Bulychev A, Mobashery S. Class C beta-lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates. Antimicrob Agents Chemother 1999; 43: 1743–1746
   PubMed Web of Science ®Google Scholar
• Yoshimura F, Nikaido H. Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985; 27: 84–92
   PubMed Web of Science ®Google Scholar
• Domenech-Sanchez A, Hernandez-Alles S, Martinez-Martinez L, Benedi V J, Alberti S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol 1999; 181: 2726–2732
   PubMed Web of Science ®Google Scholar
• Kaczmarek F M, Dib-Hajj F, Shang W, Gootz T D. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006; 50: 3396–3406
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement, M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA 2008
   Google Scholar